Theravectys granted authorization by the French National Agency for Medicines to produce lentiviral vectors for clinical use and car-t cell therapies under GMP st : Theravectys granted authorization by the French National Agency for Medicines to produce lentiviral vectors for clinical use and car-t cell therapies under GMP standards. Cliquez ici pour en savoir plus